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Abstract: Four new ent-kaurane diterpenoids, namely, 3α-tigloyloxypterokaurene L3 (1), ent-17-hydroxy-kaura-9(11),15-dien-19-
oic acid (2), and wedelobatins A (3) and B (4), together with 11 known ent-kaurane diterpenoids (5–15), were isolated from the 
ethanol extract of Wedelia trilobata. All the structures of 1–15 were elucidated on the basis of spectroscopic studies. 
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Introduction 
Wedelia trilobata has been used as a traditional herbal  
medicine for the treatment of fever and malaria in Vietnam 
and also for the treatment of backache, stubborn wounds, sores, 
and arthritic pain in the Caribbean and Central America.1,2 
Previous phytochemical studies showed that the plants of this 
genus are a rich source of ent-kaurane diterpenoids.3–5 
As part of our efforts to assemble a large scale natural  
product library with thousands of compounds derived from 
plants and micro-organisms, phytochemical investigation on  
W. trilobata led to the isolation of four new ent-kaurane 
diterpenoids, namely, 3α-tigloyloxypterokaurene L3 (1),  
ent-17-hydroxykaura-9(11),15-dien-19-oic acid (2), and 
wedelobatins A (3) and B (4), together with 11 ent-kaurane 
derivatives, grandiflorenic acid (5),6 pterokaurene L3 (6),7  
3α-cinnamoyloxy-pterokaurene L3 (7),3 ent-3β-
cinnamoyloxykaur-16-en-19-oic acid (8),4 grandifloric acid 
(9),8 ent-17-hydroxykaur-15-en-19-oic acid (10),3 3α-
angeloyloxypterokaurene L3 (11),3 ent-3β-tigloyloxykaur-16-
en-19-oic acid (12),10 ent-3β-angeloyloxykaur-16-en-19-oic 
acid (13),3,10 12α-methoxygrandiflorenic acid (14),11 and  
12α-hydroxygrandiflorenic acid (15).12 This paper herein  
describes the isolation and structural elucidation of these new 
compounds. 
 
Results and Discussion 
3α-Tigloyloxypterokaurene L3 (1), was obtained as a white 
amorphous powder, with its molecular formula determined as 
C25H36O5 on the basis of HREIMS, showing a molecular ion 
peak at m/z 416.2554 (calcd for C25H36O5, 416.2563). The IR 
spectrum revealed absorption bands of hydroxyl (3513 cm–1), 
carbonyl (1701 cm–1), and double bond (1652 cm–1) groups. In 
the 1H NMR spectrum (Table 1), the downfield olefinic proton 
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at δH 6.86 (br. q, J = 7.1 Hz) and two methyl signals at δH 1.77 
(br. d, J = 7.1 Hz) and 1.82 (br. s), was indicated by the  
presence of a tigloyloxy group in 1.10 Apart from the five  
carbon signals assigned to the tigloyloxy group (δC 167.7, 
128.8, 137.2, 14.4, and 12.0),10 the 13C NMR (DEPT)  
spectrum (Table 1) of 1 also exhibited 20 carbons composed of 
two methyls, nine methylenes, three methines (one  
oxygenated), and six quaternary carbons, which were  
consistent with a skeleton of an ent-kauranoid.7 In particular, 
the NMR spectroscopic features of 1 are similar to those of 6 
(pterokaurene L3), which only differed in the appearance of a 
tigloyloxy group at C-3 in 1. It was also confirmed by the 
chemical shift value of C-3 (C 78.7, CH), C-9 (C 77.3, C) 
and the HMBC correlations (Figure 1) from H-3 (H 4.60, dd, 
J = 12.1, 4.5 Hz) to C-1′ (C 167.7, C), C-1 (C 30.6, CH2), and 
C-18 (C 24.1, CH3) as well as the correlations from Me-20, 
H-12, and H-15 to C-9, and from the methyl at C-4 (Me-18) to 
a downfield quaternary carbon (C-19) at δC 180.2. The β-
orientation of the hydroxy group at C-9 in 1 was based on the 
downfield shift of H-15β (H 2.70) and upfield shift of C-15 
(C 43.7) for the -steric compression effect in 1 from the  
hydroxyl group at C-9 to H-15 as evidenced in pterokaurene 
L3 (6).7 Furthermore, the ROESY correlations (Figure 2) of  
H-3 with H-5 and Me-18 suggested that the tigloyloxy was  
α-orientated. Consequently, the structure of 1 was finally  
determined as ent-3β-tigloyloxy-9α-hydroxykaur-16-en-19-oic 
acid, and given the name as 3α-tigloyloxypterokaurene L3. 
ent-17-Hydroxykaura-9(11),15-dien-19-oic acid (2), was 
obtained as a white, amorphous powder, with a molecular 
formula of C20H28O3 on the basis of HREIMS, showing a  
molecular ion peak at m/z 316.2028 (calcd for C20H28O3, 
316.2038). The IR spectrum indicated the presence of hydroxyl
(3427 cm–1), carbonyl (1693 cm–1), and double bond  
(1639 cm–1) groups. The 13C NMR (DEPT) spectrum (Table 1) 
revealed 20 carbons including three sp3 quaternary carbons, 
three sp2 quaternary carbons (one carboxylic acid carbonyl), 
two sp3 methines, two sp2 methines, eight sp3 methylenes (one 
oxygenated), and two methyl groups. Its 1H NMR spectrum 
(Table 1) showed two olefinic protons at δH 6.01 (s) and 5.00 
(dd, J = 3.7, 3.1 Hz), two AB double doublets assigned to the 
protons of a hydroxymethyl group at δH 4.25 (dd, J = 14.1, 1.4 
Hz) and 4.21 (dd, J = 14.1, 0.9 Hz), and two methyl signals at 
δH 1.24 and 1.01 (each 3H, s). These spectroscopic features 




δC, type δH (J in Hz) δC, type δH (J in Hz) 
1 30.6, CH2 2.03, td (13.1, 4.1); 1.63a 39.8, CH2 1.86a; 1.22, td (13.9, 3.3) 
2 23.8, CH2 2.40, dddd (13.5, 13.1, 12.1, 4.1); 1.79a 20.0, CH2 1.86a; 1.48a 
3 78.7, CH 4.60, dd (12.1, 4.5) 38.2, CH2 2.13, br. d (13.2); 1.01a 
4 48.0, C  44.9, C  
5 49.2, CH 1.79a 47.2, CH 1.48a 
6 21.4, CH2 1.86, m; 1.70, m 18.4, CH2 2.44, br. q-like (11.5); 1.96, m 
7 35.9, CH2 1.84, m; 1.28a 27.1, CH2 1.86a; 1.48a 
8 49.0, C  45.9, C  
9 77.3, C  157.2, C  
10 43.7, C  38.1, C  
11 30.0, CH2 1.99, br. dd (14.9. 5.6); 1.24, m 113.5, CH 5.00, dd (3.7, 3.1) 
12 34.4, CH2 1.64a; 1.58, m 27.9, CH2 2.27, ddd (18.1, 5.0, 3.1); 1.92, br. dd (18.1, 3.7) 
13 42.1, CH 2.62, br. s 38.8, CH 2.69, dd (5.0, 4.8) 
14 40.3, CH2 2.13, dd (11.9, 2.4); 1.27a 49.2, CH2 1.63, br. d (9.2); 1.82, dd (9.2, 4.8) 
15 43.7, CH2 1.80a; 2.70, br. d (17.8) 137.2, CH 6.01, s 
16 154.6, C  143.4, C  
17 103.4, CH2 4.81, br. s; 4.78, br. s 60.7, CH2 4.25, dd (14.1, 1.4); 4.21, dd (14.1, 0.9) 
18 24.1, CH3 1.27, s 28.3, CH3 1.24, s 
19 180.2, C  183.6, C  
20 17.3, CH3 1.16, s 23.0, CH3 1.01, s 
1′ 167.7, C    
2′ 128.8, C    
3′ 137.2, CH 6.86, br. q (7.1)   
4′ 14.4, CH3 1.77, br. d (7.1) 
5′ 12.0, CH3 1.82, br. s   
asignal overlapped 
 





Figure 2.  Key ROESY correlations of compound 1 
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suggested that the structure of 2 was similar to that of 10 (ent-
17-hydroxykaur-15-en-19-oic acid),3 and only differed in  
appearance as a double bond between C-9 (C 157.2, C) and 
C-11 (C 113.5, CH) in 2. It was confirmed by, the HMBC 
correlations from H-11 (H 5.00, dd, J = 3.7, 3.1 Hz) to C-8 
(C 45.9, C), C-10 (C 38.1, C), and C-13 (C 38.8, CH), as 
shown in Figure 1. The α-orientation of the carboxylic acid 
group at C-4 was inferred from the 13C NMR chemical shift of 
the methyl group at C-4 by comparing those of related ent-
kaurane diterpenoids, in which the methyl group with  
β-orientation resulted in resonance of approximately δC 29, as 
opposed to resonance of approximately δC 16 when the methyl 
group was in the α-orientation.7,13,14 Accordingly, the structure 
of compound 2 was elucidated as ent-17-hydroxykaura-
9(11),15-dien-19-oic acid. 
Wedelobatin A (3), was obtained as a colorless oil, which 
has a molecular formula of C30H46O3 on the basis of HREIMS, 
showing a molecular ion peak at m/z 454.3454 (calcd for 
C30H46O3, 454.3447). The IR spectrum suggested the presence 
of hydroxyl (3428 cm–1), carbonyl (1719 cm–1), and double 
bond (1657 cm–1) groups. In the 13C NMR (DEPT) spectrum 
(Table 2), 20 carbon signals including two methyl carbons, 
nine methylenes, three methines, four quaternary carbons, and 
two carbons of one double bond, suggested the presence of an 
ent-kaurene skeleton, which was confirmed by the typical 1H 
NMR signals (Table 2) of ent-kaurene as follows: δ 4.79 (1H, 
br. s), 4.73 (1H, br. s), 2.63 (1H, br. s), 1.18 (3H, s), and 0.91 
(3H, s). Particularly, the NMR signals of the ent-kaurane  
moiety were in accordance with those of ent-kaurenoic acid.7 
On the other hand, the remaining carbon signals were  
composed of two olefinic carbons of a trisubstituted double 
bond, three methyl carbons, one methylene, and four methines 
(two oxygenated), together with the 1H NMR signals at δ 5.43 
(1H, br. s), 5.15 (1H, br. d, J = 8.4 Hz), 4.02 (1H, t, J = 3.3 
Hz), 1.81 (3H, s), 0.96, and 0.83 (each 3H, d, J = 6.8 Hz), 
resembled those of (3R,4R,6S)-3,6-dihydroxymenth-1-ene.15,16 
As shown in Figure 3, the cyclohexene ring in the monoterpene
moiety should have half chair configuration. The coupling 
constant of H-3′ (br. d, J = 8.4 Hz) indicated a trans pseudo-
diaxial relationship for H-3′ and H-4′ while those of H-6′ (t, J 
= 3.3 Hz) suggested an equatorial orientation. Consequently, 
H-3′, H-4′, and H-6′ were determined to be α-, β-, and  
α-oriented, respectively. The observation of the HMBC  
correlation (Figure 1) from H-3′ to C-19 as well as the down-
field chemical shift of H-3′ at δH 5.15 and the upfield chemical 
shift of C-19 at δC 177.4, indicated the linkage between the 
two moieties at C-3′ and C-19 via an ester connection.  
Therefore, the structure of wedelobatin A was elucidated, as 
shown in Figure 1. 
Wedelobatin B (4), was obtained as a colorless oil, and  
determined molecular formula of C30H44O3 on the basis of 
HREIMS, showing a molecular ion peak at m/z 452.3283 
(calcd for C30H44O3, 452.3290). The IR spectrum suggested the 
presence of hydroxyl (3429 cm–1), carbonyl (1716 cm–1), and 
double bond (1654 cm−1) groups. The 1H and 13C NMR data 
(Table 2) of 4 were similar to those of 3. The major difference 
found was the presence of one more olefinic proton at δH 5.23 
(dd, J = 3.5, 2.7 Hz) and two olefinic carbons of a trisubstituted
double bond in 4. The double bond was located at C-9 based 
on the HMBC correlations from H-11 to C-8, C-10, and C-13, 
which was confirmed by the fact that the NMR data of the  
ent-kaurene moiety were consistent with those of 5. Hence, the 




General Experimental Procedures. Optical rotations were 
measured on a Jasco P-1020 polarimeter. IR spectra were  
obtained by using a Bruker Tensor 27 FT-IR spectrometer 
with KBr pellets. NMR spectra were acquired with a Bruker 
AVANCE Ⅲ-600, Bruker DRX-500 or Bruker AV-400  
instrument at room temperature. ESIMS and HREIMS were 
recorded on a Bruker HCT/Esquire and Waters AutoSpec-
P776 mass spectrometers. Silica gel (200–300 mesh, Qingdao  
Marine Chemical Co., Ltd., China), MCI gel CHP-20P (75–
150 μm, Mitsubishi Chemical Corporation, Japan), Sephadex 
LH-20 (Amersham Biosciences, Sweden) and Chromatorex  
C-18 (40–75 μm, Fuji Silysia Chemical Ltd., Japan) were used 
for normal pressure column chromatography. MPLC was  
performed on a Büchi Sepacore System including pump  
manager C-615, pump modules C-605, and fraction collector 
C-660 (Büchi Labortechnik AG, Switzerland) and columns 
were packed with Chromatorex C-18 (40–75 μm, Fuji Silysia 
Chemical Ltd., Japan). Preparative HPLC was performed on 
an Agilent 1200 liquid chromatography apparatus with a 
Zorbax SB-C18 column (5 μm, 9.4 mm × 150 mm). Fractions 
were monitored and analyzed by TLC (Qingdao Marine 
Chemical Co., Ltd., China) and spots were visualized by  
heating silica gel plates immersed in vanillin–H2SO4 in EtOH. 
 
Plant Material. The whole plants of W. trilobata were  
collected in Pu'er City of Yunnan Province, China, in  
November 2010, and identified by Mr. Yu Chen of Kunming 
Institute of Botany, Chinese Academy of Sciences. The 
voucher specimen (BBP0311) was deposited at BioBioPha Co., 
Ltd. 
 
Extraction and Isolation. The air-dried, powdered whole 
plants of W. trilobata (10.0 kg) were extracted with 95%  
ethanol at room temperature. The alcohol extract was  
concentrated to derive a residue (1180 g), which was  
fractionalized by silica gel column chromatography eluted 
with a solvent system of petroleum ether (PE)-acetone and 
then MeOH to yield fractions 1–6. Fraction 1 (30 g), eluted 
with 10% acetone, was further isolated and purified by  
recrystallization from PE-acetone to afford 5 (17.5 mg).  
Fraction 2 (48 g), eluted with 15% acetone, was further  
separated by silica gel column (CHCl3-acetone, 60:1), and then 
by preparative HPLC (CH3CN-H2O, 50%→70%, 10 mL/min) 
to derive 3 (4 mg), 4 (4 mg), 12 (48 mg), and 13 (8 mg).  
Fraction 3 (28 g), was eluted using 20% acetone, and  
 
Figure 3.  Configuration of the monoterpene moiety 
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subsequently subjected to a silica gel column with a gradient 
elution (PE-acetone, 40:1→15:1) to yield fractions 3a–3c. 
Fraction 3a (6.5 g) yielded 6 (40 mg) and 8 (166 mg) after 
passing over a MCI gel (MeOH, 100%) and MPLC (MeOH-
H2O, 75%→82%, 10 mL/min). 1 (24 mg) and 11 (70 mg) were 
purified from fraction 3b (7.8 g) through a silica gel column 
(PE-acetone, 8:1). Fraction 3c (8.5 g) was further separated by 
silica gel (PE-acetone, 8:1), RP-18 (MeOH-H2O, 70%), and 
silica gel-AgNO3 (PE-acetone, 3:1→2:1) to yield 2 (16 mg), 7 
(170 mg), 9 (25 mg), and 10 (9 mg). Fraction 5 (4.2 g), was 
eluted using 30% acetone, and purified using a silica gel  
column (PE-EtOAc, 4:1→3:1) to afford 14 (8 mg) and 15  
(22 mg). 
 
3α-Tigloyloxypterokaurene L3 (1): amorphous powder; 
[α]19D   – 72.9 (c 0.24, CHCl3); IR (KBr) νmax 3513, 2943, 2933, 
2859, 1701, 1652, 1450, 1380, 1274, 1258, 1209, 1170, 1152, 
1133, 1041, 970 cm–1; 1H NMR and 13C NMR data, see Table 
1; ESIMS (pos.) m/z 439 [M + Na]+; HREIMS m/z 416.2554 
(calcd for C25H36O5, 416.2563). 
 
ent-17-Hydroxykaura-9(11),15-dien-19-oic acid (2): 
amorphous powder; [α]19D   – 43.6 (c 0.25, CHCl3); IR (KBr) 
νmax 3427, 3031, 2928, 2969, 1693, 1639, 1464, 1377, 1228, 
1158, 1118, 1003, 988 cm–1; 1H NMR and 13C NMR data, see 
Table 1; ESIMS (neg.) m/z 315 [M – H]–, HREIMS m/z 
316.2028 (calcd for C20H28O3, 316.2038). 
 
Wedelobatin A (3): oil; [α]22D   – 121.8 (c 0.41, CHCl3); IR 
(KBr) νmax 3428, 2956, 2929, 2872, 2853, 1719, 1657, 1465, 
1447, 1386, 1369, 1227, 1149, 1015 cm–1; 1H NMR and 13C 
NMR data, see Table 2; ESIMS (pos.) m/z 477 [M + Na]+, 
HREIMS m/z 454.3454 (calcd for C30H46O3, 454.3447). 
 
Wedelobatin B (4): oil; [α]21D   – 29.2 (c 0.31, CHCl3); IR 
(KBr) νmax 3429, 2957, 2929, 2870, 1716, 1654, 1464, 1377, 
1219, 1144, 1045, 1015, 985 cm–1; 1H NMR and 13C NMR 
data, see Table 2; ESIMS (pos.) m/z 475 [M + Na]+, HREIMS 
m/z 452.3283 (calcd for C30H44O3, 452.3290). 
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